ANNOUNCEMENT {#s1}
============

Salmonella enterica serovar Dublin, a significant cause of foodborne diseases for animals and humans, is generally transmitted through unpasteurized milk and cheese ([@B1], [@B2]). It is also known to have a propensity for causing invasive infections with multidrug resistance, which complicates the therapeutic approach ([@B1], [@B3][@B4][@B6]). In this report, we present seven draft genome sequences of *S*. Dublin isolates collected from humans in Nebraska.

Blood, MacConkey, chocolate, and/or Hektoen enteric agar plates were used to culture human stool, blood, and synovial fluid specimens. Bacterial cultures were incubated overnight at 35°C. *Salmonella* species are non-lactose fermenters and H~2~S producers. A MicroScan WalkAway system (Beckman Coulter, Brea, CA) was used for identification of *Salmonella* species ([Table 1](#tab1){ref-type="table"}). Serovar designations were made by pulsed-field gel electrophoresis and subsequently confirmed by whole-genome sequencing (WGS) using the MiSeq platform (Illumina, CA, USA). Strains from overnight cultures were tested for antimicrobial susceptibility to certain antibiotics using the disk diffusion method and interpreted using CLSI guidelines ([Table 1](#tab1){ref-type="table"}).

###### 

Summary characteristics of whole-genome sequencing of multidrug-resistant *Salmonella* serovar Dublin strains[^*a*^](#ngtab1.1){ref-type="table-fn"}

  Strain                                             No. of contigs   Genome size (bp)   *N*~50~   GC content (%)   No. of genes   RNA genes   AMR phenotype[^*b*^](#ngtab1.2){ref-type="table-fn"}   Resistance genes[^*c*^](#ngtab1.3){ref-type="table-fn"}                            GenBank accession no.                                               SRA accession no.[^*d*^](#ngtab1.4){ref-type="table-fn"}
  -------------------------------------------------- ---------------- ------------------ --------- ---------------- -------------- ----------- ------------------------------------------------------ ---------------------------------------------------------------------------------- ------------------------------------------------------------------- -----------------------------------------------------------
  SD_190068                                          92               4,923,539          405,624   52.11            4,989          114         AM, CAZ, TE, C                                         *bla*~CMY-2~, *bla*~TEM-1B~, *floR*, *strA*, *strB*, *sul2*, *tetA*                [VACG00000000](https://www.ncbi.nlm.nih.gov/nuccore/VACG00000000)   [SRR9641963](https://www.ncbi.nlm.nih.gov/sra/SRR9641963)
  SD_180610                                          45               4,978,985          478,715   52.11            5,016          112         AM, CAZ, TE, C                                         *bla*~CMY-2~, *bla*~TEM-1B~, *floR*, *strA*, *strB*, *sul2*, *tetA*                [VDCP00000000](https://www.ncbi.nlm.nih.gov/nuccore/VDCP00000000)   [SRR9641967](https://www.ncbi.nlm.nih.gov/sra/SRR9641967)
  SD_180280[^*e*^](#ngtab1.5){ref-type="table-fn"}   50               4,979,905          494,424   52.11            5,032          115         AM, CAZ, TE, C, CIP                                    *bla*~CMY-2~, *bla*~TEM-1B~, *floR*, *strA*, *strB*, *sul2*, *tetA*, *gyrA* D87N   [VACH00000000](https://www.ncbi.nlm.nih.gov/nuccore/VACH00000000)   [SRR9641964](https://www.ncbi.nlm.nih.gov/sra/SRR9641964)
  SD_170735[^*e*^](#ngtab1.5){ref-type="table-fn"}   65               5,136,349          402,292   52.11            5,179          121         AM, CAZ, TE, C, CIP                                    *bla*~CMY-2~, *bla*~TEM-1B~, *floR*, *strA*, *strB*, *sul2*, *tetA*, *gyrA* D87G   [VACM00000000](https://www.ncbi.nlm.nih.gov/nuccore/VACM00000000)   [SRR9641961](https://www.ncbi.nlm.nih.gov/sra/SRR9641961)
  SD_170156                                          73               4,962,240          420,579   52.09            5,035          116         AM, CAZ, TE, C                                         *bla*~CMY-2~, *floR*, *strA*, *strB*, *sul2*, *tetA*                               [VACN00000000](https://www.ncbi.nlm.nih.gov/nuccore/VACN00000000)   [SRR9641962](https://www.ncbi.nlm.nih.gov/sra/SRR9641962)
  SD_12500                                           51               4,984,528          478,716   52.1             5,032          117         AM, CAZ, TE, C, SXT                                    *bla*~CMY2~, *bla*~TEM-1B~, *floR*, *strA*, *tetA*, *strB*, *sul2*                 [VACK00000000](https://www.ncbi.nlm.nih.gov/nuccore/VACK00000000)   [SRR9641959](https://www.ncbi.nlm.nih.gov/sra/SRR9641959)
  SD_7855                                            75               5,095,495          204,878   51.89            5,171          117         AM, TE, C                                              *bla*~TEM-1A~, *catA1*, *strA*, *strB*, *sul1*, *tetB*, *aadA1*, *aph(3′)-Ic*      [VACJ00000000](https://www.ncbi.nlm.nih.gov/nuccore/VACJ00000000)   [SRR9641966](https://www.ncbi.nlm.nih.gov/sra/SRR9641966)

Sequence type by MLST for all strains was sequence type 10 (ST10).

Testing performed by the disc diffusion method. AMR, antimicrobial resistance; AM, ampicillin; CAZ, ceftazidime; TE, tetracycline; C, chloramphenicol; CIP, ciprofloxacin; SXT, trimethoprim-sulfamethoxazole.

β-Lactam resistance genes, *bla*~CMY-2~, *bla*~TEM-1B~; chloramphenicol resistance genes, *floR* and *catA1*; fluoroquinolone resistance genes, *gyrA* mutations; aminoglycoside resistance genes, *strA*, *strB*, *aadA1*, and *aph(3′)-Ic*; tetracycline resistance genes, *tetA* and *tetB*; sulfonamide resistance genes, *sul1* and *sul2*.

SRA, Sequence Read Archive.

These two strains showed intermediate susceptibility to ciprofloxacin due to *gyrA* mutations.

A single colony of an overnight blood agar plate culture at 35°C was used for genomic DNA extraction using the MagNA Pure compact nucleic acid isolation kit I using the MagNA Pure compact instrument (Roche Diagnostics, IN, USA). DNA quality and quantity were determined using the NanoDrop 2000 UV-visible spectrophotometer (Fisher, MA, USA) and the Qubit 3.0 fluorometer (Invitrogen, CA, USA), respectively.

Genomic libraries were prepared using the Nextera XT library prep kit (Illumina) as instructed by the manufacturer. WGS was performed according to the manufacturer's protocol using a 250-bp paired-end chemistry. The following parameters were used to assess the quality of the run: Phred quality score (quality score 30 \> 75%), cluster density (600 to 1,300), and percentage of clusters passing filters (\>80%). Default parameters were used for all bioinformatics software unless otherwise specified. The quality of the sequence reads was evaluated using FastQC 0.10. After subsequent quality trimming using Trimmomatic 0.33, the contigs of genomic sequences were *de novo* assembled using SPAdes 3.12, and contigs with a size less than 200 bp were filtered out using BBmap 38.06. The quality of the *de novo* assembled genomes were determined using QUAST 4.1 ([Table 1](#tab1){ref-type="table"}). The draft genome of each strain was annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) 4.8 (<https://www.ncbi.nlm.nih.gov/genome/annotation_prok/>). All bioinformatics tools used in this study except PGAP were made available through <https://github.com/github>.

The multilocus sequence types (MLST) were determined using MLST 2.0 as previously described ([@B7]). ResFinder 3.1 was used to identify antimicrobial resistance determinants, including acquired resistance genes and/or chromosomal mutations ([@B8]).

The average genome size of the sequenced isolates was 5,008,720 bp (range, 4,859,717 to 5,136,349 bp), the average number of contigs was 64 (range, 45 to 92), and the average *N*~50~ value was 412,175 (range, 204,878 to 494,424) ([Table 1](#tab1){ref-type="table"}).

The collected data provides a basis for comparison with other *S*. Dublin strains and studies for epidemiology, surveillance, antimicrobial resistance, and pathogenesis.

Data availability. {#s1.1}
------------------

The BioProject number for these sequences is [PRJNA541980](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA541980). GenBank accession numbers, Sequence Read Archive (SRA) accession numbers, numbers of contigs, *N*~50~ values, numbers of RNA genes, MLSTs, susceptibilities, and genotypic resistance profiles are provided in [Table 1](#tab1){ref-type="table"}.
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